A summary of important health news from the past week.
VA sets national policy for robotic legs for paralyzed vets
Veterans successfully petitioned the U.S. Department of Veteran Affairs, or the VA, to cover the cost of robot legs for veterans. The new technology, called ReWalk, costs $77,000 and most private insurance companies do not cover the device.
The National Employment Law Project, a labor advocacy group, released stating that poor oversight and regulations make it difficult to ensure labor and wage laws are upheld for roughly 2 million home care workers. Recently, home care workers, who provide health services provided for by federal and state programs through private companies, won federal minimum wage protections and overtime protections. The next step is to ensure these protections are upheld.
GlaxoSmithKline Buys Bristol-Myers Squibb’s HIV Assets
Pharmaceutical company, GlaxoSmithKline, has acquired Bristol-Myers Squibb's portfolio and discovery stage HIV research assets for $1.5 billion. This deal includes fostemsavir which the FDA has designated as a breakthrough therapy set for approval in 2018. The acquisition solidifies GSK's leadership in the HIV market
A new scientifically validated hearing test that can be taken on the phone can help individuals discover if they have any hearing loss for only $5. Although about 80% of people who take the test are found to have some level of hearing loss, only 20% then go to see a specialist.
Who We Are
The Center is the hub of the science of human health for students, faculty, and staff at Emory University.